Pfizer (PFE) Tops Q3 EPS by 1c, Updates FY Guidance
Tweet
Share
E-mail
Get Alerts PFE Hot Sheet
Price: $26.32 --0%
EPS Growth %: -58.5%
Financial Fact:
Research and development expenses: 1.88B
Today's EPS Names:
SEIC, OSBC, USAP, More
EPS Growth %: -58.5%
Financial Fact:
Research and development expenses: 1.88B
Today's EPS Names:
SEIC, OSBC, USAP, More
Join SI Premium – FREE
Pfizer (NYSE: PFE) reported Q3 EPS of $0.72, $0.01 better than the analyst estimate of $0.71. Revenue for the quarter came in at $12.1 billion versus the consensus estimate of $12.33 billion.
GUIDANCE:
Pfizer sees FY2020 EPS of $2.88-$2.93, versus the consensus of $2.90. Pfizer sees FY2020 revenue of $48.8-49.5 billion, versus the consensus of $49.34 billion.
For earnings history and earnings-related data on Pfizer (PFE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Visa (V) stock rises as Q2 earnings, revenue come ahead of estimates
- IDEX Corp. (IEX) Tops Q1 EPS by 13c ; Offers Guidance
- Retail Opportunity Investments (ROIC) Tops Q1 EPS by 2c, reaffirms guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
